Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Click here for the RSS feed for Publications IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Page 1 of 2
Date Title
12/12/2006 NovoRapid (insulin aspart) and Levemir (insulin detemir) - Important Safety Information from Novo Nordisk as approved from the Irish Medicines Board
01/12/2006 Glivec (imatinib) - Important Safety Information from Novartis as approved by the Irish Medicines Board
01/12/2006 Medical Devices Newsletter No. 18 - December 2006
01/11/2006 Guidlines for Pharmacogenetic research
01/11/2006 Protocol Template for Investigator-Led Trials
01/11/2006 Academic Clinical Research - support from ICRIN and IDA Ireland
01/10/2006 Drug Safety Newsletter 23rd Edition
11/09/2006 Ritalin (methylphenidate hydrochloride) and Ritalin LA (methylphenidate hydrochloride) - Important Safety Information from Novartis as approved by the Irish Medicines Board
01/09/2006 IMB Newsletter Issue No.24 April - September 2006
04/08/2006 Aptivus (tipranavir) - Important Safety Information from Boehringer Ingelheim as approved by the Irish Medicines Board
01/08/2006 Minimum Requirements for Blood Bank Compliance with Article 14 (Traceability) and Article 15 (Notification of Serious Adverse Reactions and Events) of EU Directive 2002/98/EC
01/08/2006 Medical Devices Newsletter No. 17 - August 2006
21/07/2006 Iris Syndrome (IFIS) and Tamsulosin - Important Safety Information from Astellas as approved by the Irish Medicines Board
07/07/2006 HBVAXPRO Hepatitis B vaccine - Important Safety Information from Sanofi Pasteur MSD as approved by the Irish Medicines Board
30/06/2006 Variations :Dossier requirements for Type IA and Type IB notifications: European Commission Guidance
23/06/2006 Xigris (drotrecogin alfa) - Important safety information received from Eli Lilly as approved by the Irish Medicines Board
21/06/2006 IMB Newsletter Issue No.23 January – April 2006
19/06/2006 Livial (tibolone) - Important safety information from Akzo Nobel as approved by the Irish Medicines Board
19/06/2006 Lamictal (lamotrigine) - Important safety information from GlaxoSmithKline as approved by the Irish Medicines Board
07/06/2006 Remicade (infliximab) - Important safety information from Centocor and Schering Plough as approved by the Irish Medicines Board
Page 1 of 2



Date Printed: 19 June 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971